S. Chuang

发表

Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus

K. Reddy, E. Gane, D. Brainard, 2015, Hepatology.

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.

H. Mo, P. Pang, K. Kowdley, 2016, Gastroenterology.

Outcomes of Treatment with Ledipasvir and Sofosbuvir Short Title : Ledipasvir / Sofosbuvir Baseline RASs and Treatment Outcomes

H. Mo, P. Pang, K. Kowdley, 2016 .

Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection.

H. Hsu, Ding‐Shinn Chen, J. Sung, 1987, Journal of hepatology.

Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies

P. Chang, F. Bellanti, B. Bartok, 2021, British journal of clinical pharmacology.

Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

H. Hsu, J. Sung, M. Lai, 1986, Journal of hepatology.

Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma.

H. Hsu, Ding‐Shinn Chen, J. Sheu, 1987, Journal of hepatology.

Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease

Y. C. Chen, F. Lee, C. H. Wang, 1990, British journal of haematology.

Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus

K. Reddy, E. Gane, D. Brainard, 2015, Hepatology.